Abstract
Minor histocompatibility (H) antigen mismatching leads to clinically relevant alloimmune reactivity. Depending on the tissue expression pattern of the involved minor H antigens, the immune response may either cause graft-versus-host disease and a graft-versus-tumor effect or lead to only a graft-versus-leukemia effect. Thus, identification of recipient–donor pairs with minor H antigen mismatches has clinical importance. This chapter describes molecular typing methods for molecular typing of minor H antigens.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Goulmy E (1996) Human minor histocompatibility antigens. Curr Opin Immunol 8:75–81
Hambach L, Goulmy E (2005) Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 17:202–210
Cai J, Lee J, Jankowska-Gan E, Derks R et al (2004) Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199:1017–1023
Verdijk RM, Kloosterman A, Pool J et al (2004) Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103:1961–1964
Mommaas B, Stegehuis-Kamp JA, Van Halteren AG et al (2004) Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105:1823–1827
Van Halteren AG, Jankowska-Gan E, Joosten A et al (2009) Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114: 2263–2272
Nielsen HS, Wu F, Aghai Z et al (2010) H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male: female ratio in subsequent live births. Hum Reprod 25: 2745–2752
Mutis T, Goulmy E (2002) Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies. Semin Hematol 39:23–31
Klein CA, Wilke M, Pool J et al (2002) The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 196: 359–368
Fujii N, Hiraki A, Ikeda K et al (2002) Expression of minor histocompatibility antigen, HA-1, in solid tumor cells. Transplantation 73:1137–1141
Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E (2010) Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients. Leukemia 24:1388–1392
Goulmy E, Termijtelen A, Bradley BA, van Rood JJ (1976) Alloimmunity to human H-Y. Lancet 2:1206
Voogt PJ, Fibbe WE, Marijt WA et al (1990) Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335: 131–134
Wilke M, Dolstra H, Maas F et al (2003) Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies. Hematol J 4: 315–320
Dolstra H, Fredrix H, Maas F et al (1999) A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 189:301–308
Goulmy E (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157:125–140
Dickinson AM, Wang XN, Sviland L et al (2002) In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 8: 410–414
de Bueger MM, Bakker A, van Rood JJ, Van der Woude F, Goulmy E (1992) Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 149:1788–1794
Dolstra H, Fredrix H, Preijers F et al (1997) Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol 158:560–565
Wilke M, Pool J, den Haan JM, Goulmy E (1998) Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 52: 312–317
Wilke M, Pool J, Goulmy E (2002) Allele specific PCR for the minor histocompatibility antigen HA-2. Tissue Antigens 59:304–307
Spierings E, Brickner AG, Caldwell JA et al (2003) The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102:621–629
den Haan JM, Sherman NE, Blokland E et al (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476–1480
Spierings E, Drabbels J, Hendriks M et al (2006) A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS ONE 1:e42
Deng G (1988) A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric-cancer. Nucleic Acids Res 16:6231
Mercier B, Ferec C, Dufosse F, Huart JJ (1992) Improvement in HLA-DQB typing by PCR-RFLP—introduction of a constant restriction site in one of the primers for digestion control. Tissue Antigens 40:86–89
Tseng LH, Lin MT, Martin PJ, Pei J, Smith AG, Hansen JA (1998) Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. Tissue Antigens 52:305–311
Pierce RA, Field ED, Mutis T et al (2001) The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 167: 3223–3230
Brickner AG, Warren EH, Caldwell JA et al (2001) The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 193: 195–206
Lo YMD, Tein MSC, Lau TK et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768–775
Murata M, Warren EH, Riddell SR (2003) A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279–1289
Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986–994
Akatsuka Y, Warren EH, Gooley TA et al (2003) Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br J Haematol 123: 671–675
Fehse B, Chukhlovin A, Kuhlcke K et al (2001) Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res 10:419–425
Longo MC, Berninger MS, Hartley JL (1990) Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125–128
Kreiter S, Wehler T, Landt O, Huber C, Derigs HG, Hess G (2000) Rapid identification of minor histocompatibility antigen HA-1 subtypes H and R using fluorescence-labeled oligonucleotides. Tissue Antigens 56:449–452
Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP (1997) Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22:130–131, and 134–138
Arguello JR, Little AM, Pay AL et al (1998) Mutation detection and typing of polymorphic loci through double-strand conformation analysis. Nat Genet 18:192–194
Arostegui JI, Gallardo D, Rodriguez-Luaces M et al (2000) Genomic typing of minor histocompatibility antigen HA-1 by reference strand mediated conformation analysis (RSCA). Tissue Antigens 56:69–76
Kamei M, Nannya Y, Torikai H et al (2009) HapMap scanning of novel human minor histocompatibility antigens. Blood 113:5041–5048
Spaapen RM, Lokhorst HM, van den Oudenalder K et al (2008) Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med 205:2863–2872
van Bergen CA, Rutten CE, van der Meijden ED et al (2010) High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 70:9073–9083
Akatsuka Y, Nishida T, Kondo E et al (2003) Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 197:1489–1500
Kawase T, Akatsuka Y, Torikai H et al (2007) Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 110:1055–1063
Tykodi SS, Fujii N, Vigneron N et al (2008) C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res 14:5260–5269
Torikai H, Akatsuka Y, Miyazaki M et al (2006) The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303. Br J Haematol 134:406–410
den Haan JM, Meadows LM, Wang W et al (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054–1057
Mommaas B, Kamp J, Drijfhout JW et al (2002) Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 169: 3131–3136
Bleakley M, Otterud BE, Richardt JL et al (2010) Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 115:4923–4933
van Bergen CA, Kester MG, Jedema I et al (2007) Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP- dependent interferon-responsive (ADIR) gene. Blood 109: 4089–4096
Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M (2009) Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 114:3684–3692
Griffioen M, van der Meijden ED, Slager EH et al (2008) Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci U S A 105: 3837–3842
de Rijke B, van Horssens-Zoetbrood A, Beekman JM et al (2005) A frame-shift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 115:3506–3516
Brickner AG, Evans AM, Mito JK et al (2006) The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 107:3779–3786
Warren EH, Gavin MA, Xuereb SM et al (2002) A single nucleotide polymorphism in the SP110 nuclear phosphoprotein gene creates a minor histocompatibility antigen whose expression is regulated by interferon-gamma. Blood 100:73A
Oostvogels R, Minnema MC, van Elk M et al (2013) Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia 27:642–649
Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH (2000) DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95:1100–1105
Pierce RA, Field ED, den Haan JM et al (1999) Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 163:6360–6364
Meadows L, Wang W, den Haan JM et al (1997) The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273–281
Torikai H, Akatsuka Y, Miyazaki M et al (2004) A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 173:7046–7054
Rosinski KV, Fujii N, Mito JK et al (2008) DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 111:4817–4826
Ivanov R, Aarts T, Hol S et al (2005) Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. Clin Cancer Res 11:1694–1703
Vogt MH, Goulmy E, Kloosterboer FM et al (2000) UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T- cell recognition. Blood 96:3126–3132
Wang W, Meadows LR, den Haan JM et al (1995) Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588–1590
Warren EH, Gavin MA, Simpson E et al (2000) The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 164: 2807–2814
Vogt MH, van den Muijsenberg J, Goulmy E et al (2002) The DBY gene codes for an HLA-DQ5 restricted human male specific minor histocompatibility antigen involved in GvHD. Blood 99:3027–3032
Zorn E, Miklos DB, Floyd BH et al (2004) Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 199:1133–1142
Spierings E, Vermeulen C, Vogt MH et al (2003) Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362:610–615
Acknowledgments
Talitha de Hoop and Walter van Ginkel, University Medical Center Utrecht, are acknowledged for developing and validating the SBT protocols; Jos Pool and Jos Drabbels, Leiden University Medical Center, for developing and validating the uniform PCR-SSP protocols; and Erik Rozemuller, GenDx BV, Utrecht, for the implementation of automated allele assignment for minor H antigens after SBT in SBTEngine©.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Spierings, E. (2014). Molecular Typing Methods for Minor Histocompatibility Antigens. In: Beksaç, M. (eds) Bone Marrow and Stem Cell Transplantation. Methods in Molecular Biology, vol 1109. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9437-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9437-9_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9436-2
Online ISBN: 978-1-4614-9437-9
eBook Packages: Springer Protocols